Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Progenics Pharmaceuticals (PGNX)

Progenics Pharmaceuticals (PGNX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.10 -0.43 (-9.49%) 06/19/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.10 unch (unch) -
Quote Overview for Fri, Jun 19th, 2020
Day Low
3.94
Day High
4.79
Open 4.60
Previous Close 4.53 4.53
Volume 34,928,300 34,928,300
Avg Vol 2,569,575 2,569,575
Stochastic %K 47.25% 47.25%
Weighted Alpha -27.10 -27.10
5-Day Change +0.06 (+1.49%) +0.06 (+1.49%)
52-Week Range 1.89 - 6.37 1.89 - 6.37
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 355,048
  • Shares Outstanding, K 86,597
  • Annual Sales, $ 34,990 K
  • Annual Income, $ -68,550 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.89
  • Price/Sales 11.20
  • Price/Cash Flow N/A
  • Price/Book 11.60
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.77
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/14/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Generic Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +434,447.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.72 +10.22%
on 05/20/20
Period Open: 3.63
4.83 -15.12%
on 06/08/20
+0.47 (+12.95%)
since 05/19/20
3-Month
2.05 +100.00%
on 03/20/20
Period Open: 2.11
4.83 -15.12%
on 06/08/20
+1.99 (+94.31%)
since 03/19/20
52-Week
1.89 +116.93%
on 03/19/20
Period Open: 4.88
6.37 -35.64%
on 12/23/19
-0.78 (-15.98%)
since 06/19/19

Business Summary

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics' first-in-class PSMA-targeted technology platform for prostate cancer includes an antibody drug conjugate therapeutic...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 5.13
1st Resistance Point 4.61
Last Price 4.10
1st Support Level 3.76
2nd Support Level 3.43
3rd Support Level N/A

See More

52-Week High 6.37
Fibonacci 61.8% 4.66
Fibonacci 50% 4.13
Last Price 4.10
Fibonacci 38.2% 3.60
52-Week Low 1.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective